Skip to content

Clinical trials

Completed Phase 4 Psychotic Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Psychotic Disorders Phase: Phase 4 Status: Completed Clear all

153 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
200111
20023
200316
200413
200513
200620
20078
20088
200910
20109
20118
20125
20133
20143
20153
20162
20183
20194
20201
20233

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed153

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company7
National Institute of Mental Health (NIMH)5
University of Massachusetts, Worcester5
Emory University4
Massachusetts General Hospital4
New York State Psychiatric Institute4
North Suffolk Mental Health Association4
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4
University of California, Los Angeles4
University of Maryland, Baltimore4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Psychotic Disorders153
Schizophrenia137
Bipolar Disorder18
Psychomotor Agitation8
Alcoholism7
Mental Disorders7
Substance-Related Disorders6
Metabolic Syndrome5
Alzheimer Disease4
Obesity4

Trials

Showing 1 to 25 of 153. Each trial links to its page on Pharma Observatory.

53 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.